Optimizing Tildrakizumab Dosing in Psoriasis: A 52-Week Multicenter Retrospective Study Comparing 100 mg and 200 mg—IL PSO (Italian Landscape Psoriasis)
Our findings confirm the superior effectiveness of tildrakizumab 200 mg over 100 mg in specific subgroups of patients with a comparable safety profile across the study period.
Authors
- Diego Orsini (ORCID: https://orcid.org/0000-0002-3190-3988)
- Luca Rapparini (ORCID: https://orcid.org/0000-0002-4029-941X)
- Angelo Valerio Marzano (ORCID: https://orcid.org/0000-0002-8160-4169)
- Simone Ribero (ORCID: https://orcid.org/0000-0002-0098-1406)
- Anna Elisabetta Cagni
- Francesco Loconsole (ORCID: https://orcid.org/0000-0003-2852-9451)
- Romina Ortega
- Luigi Gargiulo (ORCID: https://orcid.org/0000-0002-6051-1676)
- Eugenia Veronica Di Brizzi (ORCID: https://orcid.org/0000-0002-0278-2443)
- Matteo Megna (ORCID: https://orcid.org/0000-0003-1803-2046)
- Claudio Guarneri (ORCID: https://orcid.org/0000-0003-3918-8779)
- Emanuele Trovato (ORCID: https://orcid.org/0000-0001-8301-9206)
- Leonardo Zichichi
- Claudia Lasagni (ORCID: https://orcid.org/0000-0002-0370-6602)
- Piergiorgio Malagoli (ORCID: https://orcid.org/0000-0002-6181-6922)
- Pina Brianti
- Paolo Dapavo
- Aldo Cuccia (ORCID: https://orcid.org/0000-0002-0276-1554)
- Marina Venturini (ORCID: https://orcid.org/0000-0001-6800-3695)
- Santo Raffaele Mercuri (ORCID: https://orcid.org/0000-0002-9175-4574)
- Valentina Dini (ORCID: https://orcid.org/0000-0002-8537-1999)
- Antonio Costanzo (ORCID: https://orcid.org/0000-0001-9697-2557)
- Anna Balato (ORCID: https://orcid.org/0000-0001-5485-0172)
- Luca Potestio (ORCID: https://orcid.org/0000-0001-5940-0592)
- Martina Burlando (ORCID: https://orcid.org/0000-0002-4381-6718)
- Mario Valenti (ORCID: https://orcid.org/0000-0001-9140-9263)
- Alessandra Michelucci (ORCID: https://orcid.org/0000-0002-0795-0338)
- Luciano Ibba (ORCID: https://orcid.org/0000-0002-7876-4866)
- Federico Bardazzi (ORCID: https://orcid.org/0000-0001-6162-2004)
- Gaetano Licata (ORCID: https://orcid.org/0000-0002-0834-1331)
- Andrea Carugno (ORCID: https://orcid.org/0000-0002-8231-2205)
- Francesca Satolli (ORCID: https://orcid.org/0000-0003-1610-9249)
- Norma Cameli (ORCID: https://orcid.org/0000-0002-6535-6935)
- Alessandra Narcisi (ORCID: https://orcid.org/0000-0002-1938-8581)
- Francesca Maria Gaiani (ORCID: https://orcid.org/0009-0003-7613-4451)
- Maria Letizia Musumeci (ORCID: https://orcid.org/0000-0003-4993-6224)
- S. Di Giulio (ORCID: https://orcid.org/0009-0001-3780-5318)
- Maria Concetta Fargnoli
- Carlo Giovanni Carrera
- Davide Strippoli
Institutions
- University of Siena (IT)
- University of Pisa (IT)
- University of Messina (IT)
- University of Insubria (IT)
- University of Modena and Reggio Emilia (IT)
- University of Parma (IT)
- Humanitas University (IT)
- Vita-Salute San Raffaele University (IT)
- University of Milan (IT)
- University of Campania "Luigi Vanvitelli" (IT)
- Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT)
- University of Catania (IT)
- IRCCS Policlinico San Donato (IT)
- Ospedale Sant Antonio (IT)
- Alessandro Manzoni Hospital (IT)
- Azienda USL di Bologna (IT)
- San Gallicano Hospital (IT)
- Austrian Society of Dermatology and Venereology (AT)
- Ospedale San Donato (IT)
- Ospedale Policlinico San Martino (IT)
- Istituti di Ricovero e Cura a Carattere Scientifico (IT)
- IRCCS Humanitas Research Hospital (IT)
- Istituto di Ricovero e Cura a Carattere Scientifico San Raffaele (IT)
- University of Turin (IT)
- University of Bari Aldo Moro (IT)
- University of Naples Federico II (IT)
- University of Brescia (IT)
Publication Details
- Journal
- Dermatology and Therapy
- Published
- 2025-04-23
- DOI
- https://doi.org/10.1007/s13555-025-01416-z
- Citations
- 6
- Primary Topic
- Psoriasis: Treatment and Pathogenesis
- Type
- article
- Field-Weighted Citation Impact
- 4.78